Novartis Subsidiary Acquires Grunenthal Factory To Boost Generics Production In China
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - Novartis subsidiary Sandoz China has acquired a manufacturing facility from Grunenthal Pharmaceutical China to establish a new company to manufacture generic drugs in China, Sandoz announced in late December